Acondroplasia: una revisión sistemática y comprensiva de la literatura

Achondroplasia, which represents the most common non-lethal skeletal dysplasia worldwide, is an example of how a small genetic alteration can have major effects on human development. This condition, in most cases, is caused by a dominant mutation in the FGFR3 gene, which is responsible for regulating bone development. The present study aims to provide a systematic review that allows achondroplasia to be understood in all its dimensions. It considers not only its genetic and biological bases, but also its main clinical manifestations, associated complications, and the most advanced therapeutic strategies. To guide the search and selection of information, the recommendations of the PRISMA statement were used. Internationally recognized databases, such as PubMed, Scopus, and Web of Science, were consulted, with emphasis on recent studies of high methodological rigor published between 2018 and 2025. After filtering and analyzing the literature, 42 relevant studies were selected for this analysis. The results indicate that, in most cases, achondroplasia is associated with the G380R mutation in the FGFR3 gene, which induces continuous activation of the receptor and, therefore, abnormal cartilage growth. Clinically, patients usually present disproportionate short stature, shortening of the limbs, macrocephaly, and characteristic facial features. In addition, complications such as respiratory problems, neurological disorders, and progressive orthopedic diseases may occur. Regarding treatment, although it has traditionally focused on symptoms, new therapeutic options have recently been proposed. One of the most important is the use of vosoritide, which has been shown to increase growth in children with achondroplasia. In conclusion, achondroplasia is a well-characterized genetic disease that continues to pose significant clinical challenges. Therefore, continued research is a priority in order to help improve the quality of life of people with this condition.

Authors

Publication Details

Journal
Ibero Ciencias - Revista Científica y Académica
Published
2026-11-19
DOI
https://doi.org/10.63371/ic.v5.n4.a1897
Primary Topic
Connective tissue disorders research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Acondroplasia: una revisión sistemática y comprensiva de la literatura

Leslie Nicole Pérez Andrade, Ana Paula Trejos Delgado, Emily Nicol Paredes Cortés, Daniela Paulina Sailema Abril et al.
Ibero Ciencias - Revista Científica y Académica
Connective tissue disorders research
article

Acondroplasia: una revisión sistemática y comprensiva de la literatura

Leslie Nicole Pérez Andrade, Ana Paula Trejos Delgado, Emily Nicol Paredes Cortés, Daniela Paulina Sailema Abril, Camila Alejandra Arguello Layedra
article en

Abstract

Achondroplasia, which represents the most common non-lethal skeletal dysplasia worldwide, is an example of how a small genetic alteration can have major effects on human development. This condition, in most cases, is caused by a dominant mutation in the FGFR3 gene, which is responsible for regulating bone development. The present study aims to provide a systematic review that allows achondroplasia to be understood in all its dimensions. It considers not only its genetic and biological bases, but also its main clinical manifestations, associated complications, and the most advanced therapeutic strategies. To guide the search and selection of information, the recommendations of the PRISMA statement were used. Internationally recognized databases, such as PubMed, Scopus, and Web of Science, were consulted, with emphasis on recent studies of high methodological rigor published between 2018 and 2025. After filtering and analyzing the literature, 42 relevant studies were selected for this analysis. The results indicate that, in most cases, achondroplasia is associated with the G380R mutation in the FGFR3 gene, which induces continuous activation of the receptor and, therefore, abnormal cartilage growth. Clinically, patients usually present disproportionate short stature, shortening of the limbs, macrocephaly, and characteristic facial features. In addition, complications such as respiratory problems, neurological disorders, and progressive orthopedic diseases may occur. Regarding treatment, although it has traditionally focused on symptoms, new therapeutic options have recently been proposed. One of the most important is the use of vosoritide, which has been shown to increase growth in children with achondroplasia. In conclusion, achondroplasia is a well-characterized genetic disease that continues to pose significant clinical challenges. Therefore, continued research is a priority in order to help improve the quality of life of people with this condition.

Ibero Ciencias - Revista Científica y AcadémicaVol. 5(4)
Connective tissue disorders research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon